These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7681216)

  • 21. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors.
    Balzarini J; Weeger M; Camarasa MJ; De Clercq E; Uberla K
    Biochem Biophys Res Commun; 1995 Jun; 211(3):850-6. PubMed ID: 7541200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.
    Evans DB; Kézdy FJ; Tarpley G; Sharma SK
    Biotechnol Appl Biochem; 1993 Feb; 17(1):91-102. PubMed ID: 7679907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
    Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.
    Meyer PR; Matsuura SE; Zonarich D; Chopra RR; Pendarvis E; Bazmi HZ; Mellors JW; Scott WA
    J Virol; 2003 Jun; 77(11):6127-37. PubMed ID: 12743270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active site studies of human immunodeficiency virus reverse transcriptase.
    Mitchell LL; Cooperman BS
    Biochemistry; 1992 Aug; 31(33):7707-13. PubMed ID: 1380826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?
    Stein CA; Tonkinson JL; Yakubov L
    Pharmacol Ther; 1991 Dec; 52(3):365-84. PubMed ID: 1668180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
    Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
    Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric inhibitors against HIV-1 reverse transcriptase: design and synthesis of MKC-442 analogues having an omega-functionalized acyclic structure.
    Tanaka H; Walker RT; Hopkins AL; Ren J; Jones EY; Fujimoto K; Hayashi M; Miyasaka T; Baba M; Stammers DK; Stuart DI
    Antivir Chem Chemother; 1998 Jul; 9(4):325-32. PubMed ID: 9875411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
    J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.
    Kleim JP; Rösner M; Winkler I; Paessens A; Kirsch R; Hsiou Y; Arnold E; Riess G
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):34-8. PubMed ID: 8552634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
    Tuerk C; MacDougal S; Gold L
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6988-92. PubMed ID: 1379730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase.
    Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA
    Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitors.
    Balzarini J; Kleim JP; Riess G; Camarasa MJ; De Clercq E; Karlsson A
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1305-12. PubMed ID: 7517668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
    Debyser Z; De Vreese K; Knops-Gerrits PP; Baekelandt V; Bhikhabhai R; Strandberg B; Pauwels R; Anné J; Desmyter J; De Clercq E
    Mol Pharmacol; 1993 Apr; 43(4):521-6. PubMed ID: 7682649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
    Ma QF; Bathurst IC; Barr PJ; Kenyon GL
    Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase.
    Müller WE; Weiler BE; Charubala R; Pfleiderer W; Leserman L; Sobol RW; Suhadolnik RJ; Schröder HC
    Biochemistry; 1991 Feb; 30(8):2027-33. PubMed ID: 1705437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
    Vernekar SK; Liu Z; Nagy E; Miller L; Kirby KA; Wilson DJ; Kankanala J; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2015 Jan; 58(2):651-64. PubMed ID: 25522204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
    Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
    Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.